Latest action: Referred to the House Committee on Energy and Commerce.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill addresses baby formula safety and supply issues through regulatory and manufacturing measures.
The problem
Baby formula shortages and safety concerns have created challenges for families. Regulatory barriers and supply chain issues may limit formula availability and variety.
The proposal
The bill likely modifies FDA regulations, improves safety standards, and removes barriers to formula production and importation to ensure consistent safe supply.
The impact
Families with infants, formula manufacturers, retailers, and healthcare providers are affected. Changes could improve access and safety of baby formula products.
Removing regulatory barriers could make more formula brands available to families. This gives parents more choices and may lower prices through competition. Families would have easier access to needed products.
Strengthened safety measures could ensure baby formula meets high quality standards. Regular testing and oversight would protect infants from contaminated or unsafe products. Parents would have greater confidence in formula safety.
The bill may help prevent future shortages by supporting domestic production. International formula imports could supplement domestic supply during emergencies. Families would have more reliable access year-round.
Reduced regulatory costs could help formula companies invest in production. Smaller manufacturers might enter the market more easily. This could boost jobs in manufacturing and related industries.
Removing regulations might lower safety standards for baby formula. Products that fail to meet strict safety requirements could reach families. Infants are vulnerable, making safety oversight especially important.
International formulas may not meet U.S. safety or nutrition standards. Importing unregulated products could introduce health risks to babies. Quality control differences between countries create uncertainty.
Reducing barriers might allow large companies to dominate the market even more. Smaller manufacturers could struggle to compete without regulatory protections. Less competition could eventually lead to higher prices.
Without clear bill details, it is hard to evaluate actual safety impacts. Families deserve full information about what changes affect their babies. The public cannot fully assess benefits and risks.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.